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Abstract
Transforming growth factor-b1 (TGF-b1) signaling plays a key role in vertebrate development, homeostasis, and disease.
Nuclear factor I-C (NFI-C) has been implicated in TGF-b1 signaling, extracellular matrix gene transcription, and tooth root
development. However, the functional relationship between NFI-C and TGF-b1 signaling remains uncharacterized. The
purpose of this study was to identify the molecular interactions between NFI-C and TGF-b1 signaling in mouse
odontoblasts. Real-time polymerase chain reaction and western analysis demonstrated that NFI-C expression levels were
inversely proportional to levels of TGF-b1 signaling molecules during in vitro odontoblast differentiation. Western blot and
immunofluorescence results showed that NFI-C was significantly degraded after TGF-b1 addition in odontoblasts, and the
formation of the Smad3 complex was essential for NFI-C degradation. Additionally, ubiquitination assay results showed that
Smurf1 and Smurf2 induced NFI-C degradation and polyubiquitination in a TGF-b1-dependent manner. Both kinase and in
vitro binding assays revealed that the interaction between NFI-C and Smurf1/Smurf2 requires the activation of the mitogen-
activated protein kinase pathway by TGF-b1. Moreover, degradation of NFI-C induced by TGF-b1 occurred generally in cell
types other than odontoblasts in normal human breast epithelial cells. In contrast, NFI-C induced dephosphorylation of p-
Smad2/3. These results show that crosstalk between NFI-C and TGF-b1 signaling regulates cell differentiation and
homeostatic processes in odontoblasts, which might constitute a common cellular mechanism.
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Introduction
Tooth formation is regulated by sequential and reciprocal
epithelial-mesenchymal interactions. Dental epithelial cells from
the dental organ differentiate into ameloblasts, while ectome-
senchymal cells from the dental papilla differentiate into
odontoblasts [1]. Differentiating odontoblasts elongate, polarize,
and produce dentin by synthesizing and secreting dentin sialopho-
sphoprotein (DSPP) and collagen type I alpha1 (COLIA1), a
marker protein of odontoblasts [2,3]. An essential role of
odontoblasts is the production of a thick dentin layer that forms
the bulk of the tooth. However, the molecular mechanisms
underlying odontoblast differentiation are not well understood.
The nuclear factor I (NFI) family of site-specific transcription
factors, encoded by four genes in vertebrates (i.e., Nfia, Nfib, Nfic,
and Nfix), plays essential developmental roles in the transcriptional
modulation of various cell types [4]. Disruption of the Nfi genes in
mice leads to developmental defects in brain (Nfia) [5], lung and
brain (Nfib) [6,7], and brain and skeleton (Nfix) [8]. Interestingly,
knockout of the NFI-C gene in mice results in tooth defects,
including abnormal odontoblast differentiation during molar root
formation and short root formation [9].
The transforming growth factor-b (TGF-b) superfamily, includ-
ing TGF-b, activins, inhibins, and bone morphogenetic protein,
regulate cell proliferation, cell differentiation, the epithelial-to-
mesenchymal transition, and embryonic development. Several
reports have provided evidence supporting the interaction between
NFI-C and TGF-b signaling. The NFIC-binding site was found to
overlap with the TGF-b response element in the promoter regions
of extracellular matrix genes, including rat bone sialoprotein (BSP)
[10], the plasminogen activator inhibitor gene [11], and ColIa1
[12]. In addition, experiments searching for DNA-binding
domains of Smads and members of the NFI/CAAT box-binding
family indicated that they belong to a new superfamily of genes
[13], and that Smad3 and Smad4 interact strongly with NFI-C
through their MH1 domains [14]. However, the exact mechanism
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of the interaction between NFI-C and TGF-b signaling remains
unclear.
In the present study, we focused on NFI-C and TGF-b1, which
are essential factors for both normal odontoblast differentiation
and dentin formation. Disruption of these two genes leads to
abnormalities in these processes [15,16]. Therefore, we tested the
hypothesis that the balanced interaction between NFI-C and
TGF-b1 signaling regulates cellular differentiation and homeo-
static processes in odontoblasts.
Results
Patterns of gene expression during odontoblast
differentiation
MDPC-23 cells are immortalized undifferentiated dental papilla
cells that are capable of differentiating into odontoblasts that
express DSPP, a dentin-specific gene, and forming mineralized
nodules. To determine the stage of odontoblast differentiation in
vitro, MDPC-23 cells were cultured in differentiation medium for
up to 3 weeks and the expression levels of odontoblast
differentiation markers were analyzed by western blot and real-
time polymerase chain reaction (PCR). The formation of
mineralized nodules was evaluated by alizarin red-S staining.
The expression levels of osteocalcin mRNA gradually increased from
days 5 to 14 (Figure S1A). Expression of DSPP mRNA, a marker of
differentiated odontoblasts, was detected at day 7 and significantly
increased by day 21 (Figure S1B), while the expression of dentin
sialoprotein (DSP) was detected by western blot on day 14 and
continued to increase through day 21 (Figure 1A). Expression of
ColIa1 and dentin matrix protein 1 (DMP-1) mRNA, early marker
genes of odontoblast differentiation, increased from days 4 to 7,
and then markedly decreased at day 14 (Figure S1C and D).
Alizarin red-S staining revealed the presence of mineralized
nodules from days 7 to 21 (Figure 1B). Based on these findings, we
divided odontoblast differentiation into four stages in MDPC-23
cells: confluent (preodontoblast; day 0); early odontoblast differ-
entiation (days 0,7); late odontoblast differentiation (days 7,14);
and mineralization (days 14,21; Figure 1C).
Nfic-deficient mice have aberrant odontoblast differentiation and
dentin formation during tooth root development and higher levels
of TGFb receptor I (TGFb-RI) and p-Smad2/3 in their abnormal
odontoblasts and pulp cells [15]. Therefore, we next investigated the
expression levels of NFI-C and TGF-b signaling molecules during in
vitro odontoblast differentiation by western blot. NFI-C protein was
expressed at the beginning of the culture, decreased from days 3 to 5
(early odontoblast differentiation), increased from days 7 to 14 (late
odontoblast differentiation), and then decreased thereafter
(Figure 1D). However, the protein level of TGFb-RI, TGFb-RII,
Figure 1. Patterns of gene expression during odontoblast differentiation. MDPC-23 cells were cultured in differentiation medium for up to
3 weeks. (A) The expression of DSP was evaluated by western blot analysis. GAPDH was used as a loading control. (B) Mineralized nodules stained
with alizarin red-S were photographed. (C) Four stages of differentiation were identified: confluent (preodontoblast; 0 days); early odontoblast
differentiation (,7 days); late odontoblast differentiation (7,14 days); and mineralization (14,21 days). Solid gray bars indicate the periods of
elevated expression of genes indicated during culture. (D) The expression of NFI-C was evaluated by western blot analysis and the results were
quantified using ImageJ. (E) TGFb-RI, TGFb-RII, p-Smad2/3, Runx2, Osx, and p21 were evaluated by western blot analysis.
doi:10.1371/journal.pone.0029160.g001
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p-Smad2/3, Runx2, and p21 showed the opposite pattern to that of
NFI-C. The expression levels of those five proteins increased from
days 3 to 5, and then declined gradually from days 7 to 21,
corresponding to late odontoblast differentiation and mineralization
(Figure 1E). On the other hand, the protein level of osterix (Osx)
increased gradually in both late odontoblast differentiation and
mineralization (days 7,21; Figure 1E).
TGF-b1 induces NFI-C degradation in odontoblasts
During in vitro odontoblast differentiation, we noted inverse
patterns of expression for NFI-C and TGF-b signaling molecules
during early odontoblast differentiation (Figure 1D and E). To
determine whether the decrease in NFI-C protein levels observed
during early odontoblast differentiation was affected by TGF-b
signaling, we measured the effect of TGF-b1, TGF-b2, and TGF-
b3 treatment on the level of endogenous NFI-C protein in MDPC-
23 cells. TGF-b2 and TGF-b3 hardly influenced the level of NFI-
C protein expression but TGF-b1 decreased NFI-C protein levels
(Figure S2A). Overexpression of activated TGFb-RI also signifi-
cantly decreased NFI-C protein levels (Figure S2B). Interestingly,
the levels of NFI-C protein expression were decreased by TGF-b1
in a concentration-dependant manner (Figure S2C). In addition,
TGF-b1 increased expression levels of p-Smad2/3 and p21
(Figure 2A).
A number of intracellular proteins are degraded via the
proteasome-dependent pathway [17]. To determine whether
degradation via the proteasome is involved in the TGF-b1-
dependent reduction of NFI-C, we used MG132, a specific inhibitor
of the proteasome. Decreased levels of NFI-C were observed in the
cytoplasmic and nuclear fractions of MDPC-23 cells in response to
TGF-b1 treatment. However, pre-treatment of MDPC-23 cells with
10 mM MG132 for 1 hr prevented TGF-b1-induced NFI-C
degradation in both fractions (Figure 2B). Furthermore, NFI-C
protein accumulated in the nuclei of MDPC-23 cells after treatment
with TGF-b1 and MG132, as observed by immunofluorescence
(Figure 2C). These data suggest that the degradation of NFI-C
induced by TGF-b1 is mediated by the 26S proteasome.
Smad3 is required for the degradation of NFI-C induced
by TGF-b1
TGFb-RI is recruited and phosphorylated upon binding of
TGF-b1 to TGFb-RII. Activated TGFb-RI phosphorylates
Smad2 and Smad3, forming a complex with a common partner,
Smad4, and is subsequently translocated into the nucleus to
regulate target gene transcription [18,19,20]. To determine
whether Smad2 and Smad3 proteins have roles in the control of
NFI-C protein levels, we measured both the protein and mRNA
levels of NFI-C after either TGF-b1 treatment or overexpression
Figure 2. NFI-C is degraded by TGF-b1 in MDPC-23 cells. (A) The protein levels of NFI-C, p-Smad2/3, and p21 protein in TGF-b1-treated MDPC-
23 cells were analyzed by western blot (left panel), and the results were quantified using ImageJ (right panel). GAPDH used as a loading control. (B)
MDPC-23 cells were incubated with TGF-b1 (10 ng/ml) in the presence or absence of the proteasome inhibitor, MG132 (10 mM) for 1 hr. Cytoplasmic
and nuclear fractions were isolated and subjected to western blot analysis. GAPDH and lamin B served as cell fractionation controls. (C) The
subcellular localization of NFI-C was analyzed by immunostaining with NFI-C specific antibody. DAPI staining was used to detect nuclei.
doi:10.1371/journal.pone.0029160.g002
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of Smad2 and Smad3 in MDPC-23 cells. Endogenous NFI-C
protein was degraded when either Smad2 or Smad3 was
overexpressed in MDPC-23 cells but not when the proteasome
inhibitor MG132 was used to block NFI-C degradation
(Figure 3A). In contrast, NFI-C mRNA expression levels were
increased after TGF-b1 treatment and Smad3 overexpression
(Figure S3). These results suggest that the activation of TGF-b1
signaling resulted in the decrease of NFI-C protein levels, not via
the inhibition of NFI-C transcription but by NFI-C protein
degradation.
It was previously reported that Smad3, but not Smad2, binds to
NFI-C through its MH1 domain [14]. Therefore, we looked for
interactions between the Smads and NFI-C in immunoprecipita-
tion assays. NFI-C directly interacted with Smad3 (Figure 3B), but
not with Smad2 (data not shown). The amount of Smad3 binding
to NFI-C was increased in the presence of TGF-b1 (Figure 3B). In
the absence of TGF-b1, NFI-C was primarily localized to the
nucleus, whereas Smad3 mainly localized to the cytoplasm of
MDPC-23 cells. However, in the presence of TGF-b1, NFI-C and
Smad3 proteins both localized to the nucleus and cytoplasm.
Collectively, NFI-C and Smad3 proteins were co-localized to the
cytoplasm after TGF-b1 treatment (Figure 3C). In the presence of
MG132, TGF-b1 treatment increased the p-Smad3 in cytoplasm
and nucleus. To determine whether NFI-C interacted with Smad3
in cytoplasm or nucleus, we examined endogenous NFI-C binding
to p-Smad3 in immunoprecipitation assays in MDPC-23 cells.
Endogenous NFI-C interacted with p-Smad3 in cytoplasm and
nucleus of untreated cells. The amount of p-Smad3 binding to
NFI-C after TGF-b1 treatment was increased in the cytoplasm but
decreased in the nucleus (Figure 3D). To determine the effects of
Smad3 on the TGF-b1-induced degradation of NFI-C, we
measured the levels of NFI-C protein after siRNA-mediated
Smad3 knockdown in MDPC-23 cells. Smad3 knockdown in
MDPC-23 cells prevented the TGF-b1-induced degradation of
NFI-C (Figure 3E). These results suggest that Smad3 mediate the
degradation of NFI-C induced by TGF-b1.
Ubiquitination and degradation of NFI-C by TGF-b1 is
mediated by the ubiquitin ligases, Smurf1 and Smurf2
E3 ubiquitin (Ub) ligases play key roles in the selective
recognition of target proteins and subsequent protein degradation
by the 26S proteasome [21]. To determine whether TGF-b1
activates the E3 Ub ligases during TGF-b1-dependent NFI-C
degradation, we measured the ability of various E3 Ub ligases,
including Smurf1, Smurf2, Nedd4, and Praja1, to ubiquitinate and
degrade NFI-C in MDPC-23 cells. In the absence of TGF-b1,
exogenous NFI-C was not degraded by either Smurf1 or Smurf2;
however, in the presence of TGF-b1, both Smurf1 and Smurf2
significantly increased the degradation of NFI-C (Figure 4A). The
proteasome inhibitor MG132 inhibited the degradation of NFI-C
by Smurf1 and Smurf2 after the TGF-b1 stimulation of MDPC-23
cells (Figures 4B and S4A). In addition, Smurf1 knockdown also
blocked the degradation of endogenous NFI-C in response to
TGF-b1 (Figure 4C). We next asked whether either Smurf1 or
Smurf2 induces the ubiquitination of NFI-C after treatment with
TGF-b1. Although NFI-C showed weak polyubiquitination in the
absence of Smurf1, Smurf2, and TGF-b1, polyubiquitination of
NFI-C was increased by co-transfection of Ub with either Smurf1
or Smurf2 in HEK293T cells (Figures 4D and S4B). In particular,
Smurf1 and Smurf2 markedly increased the polyubiquitination of
NFI-C in the presence of TGF-b1 (Figures 4D and S4B). These
results indicate that the degradation and ubiquitination of NFI-C
induced by TGF-b1 signaling requires both Smurf1 and Smurf2.
The interaction of NFI-C with Smurf1 and Smurf2 requires
the activation of the MAP kinase pathway by TGF-b
signaling
To determine whether Smurf-NFI-C complexes are formed
through a direct or indirect physical interaction, we examined
endogenous NFI-C binding to Smurfs in immunoprecipitation
assays in MDPC-23 cells. Endogenous NFI-C interacted with
Smurf1 and Smurf2 in untreated cells. TGF-b1 treatment
increased the interaction of endogenous NFI-C with both Smurf1
and Smurf2 (Figures 5A and S5A). However, fibroblast growth
factor and epidermal growth factor treatment hardly influenced
the interaction of endogenous NFI-C with both Smurf1 and
Smurf2 (data not shown). We then performed immunoprecipita-
tion assays using HEK293T cells overexpressing HA-tagged NFI-
C and FLAG-tagged Smurf1 or Smurf2 proteins. NFI-C directly
interacted with both Smurf1 and Smurf2, and TGF-b1 stimulation
increased this binding (Figures 5B and S5B). These data indicate
that NFI-C binds to Smurf1 and Smurf2 in a TGF-b1-dependent
manner.
To determine whether the activation of mitogen-activated
protein kinase (MAPK) by TGF-b1 is required for the
degradation of NFI-C protein and the interaction between NFI-
C and either Smurf1 or Smurf2, we treated MDPC-23 cells with
the MEK inhibitor U0126 and analyzed the expression of NFI-C
by western blot and immunoprecipitation. NFI-C was degraded
by TGF-b1, but the addition of U0126 prevented the
degradation of NFI-C in the presence of TGF-b1 (Figure 5C).
Next, we asked whether endogenous NFI-C interaction with
either Smurf1 or Smurf2 is affected by the presence of U0126 in
MDPC-23 cells. NFI-C showed an increased interaction with
both Smurf1 and Smurf2 induced by TGF-b1, whereas U0126
decreased NFI-C binding to both Smurf1 and Smurf2 (Figures 5D
and S5C). To determine whether NFI-C was itself phosphory-
lated in response to TGF-b1 signaling, immunoprecipitates using
anti-phospho-Ser/Thr-Pro antibody were immunoblotted with
anti-NFI-C antibody. The phosphorylation of NFI-C was
increased by TGF-b1 in MDPC-23 cells (Figure 5E) as well as
in HEK293T cells after co-transfection with a MEK-CA
expression plasmid containing the constitutively active form of
MAPK-ERK kinase (Figure S6). To confirm whether NFI-C
phosphorylation downstream of MAPK activation was implicated
in the interaction between NFI-C and either Smurf1 or Smurf2,
we performed a binding assay between NFI-C and Smurf1 or
Smurf2 after dephosphorylation of phosphorylated NFI-C in vitro.
The amount of Smurf1 or Smurf2 pulled down with NFI-C in co-
immunoprecipitation assays was markedly decreased in cell
lysates treated with l-phosphatase (i.e., dephosphorylated NFI-
C), compared to untreated control (phosphorylated NFI-C;
Figures 5F and S5D). These results indicate that TGF-b1 and
MAPK activation enhance the interaction and formation of a
complex between NFI-C and Smurf1 or Smurf2, which is
required for the ubiquitination and degradation of NFI-C.
NFI-C affects dephosphorylation of p-Smad2/3
To investigate whether NFI-C affects the expression of either
Smad2/3 or Smad3 during in vitro odontoblast differentiation, we
evaluated the effects of NFI-C overexpression on the levels of
endogenous Smad2/3 protein by western blot. The results
showed that NFI-C overexpression had no influence on the
levels of total Smad2/3 protein but markedly decreased p-
Smad2/3 and p-Smad3 protein levels, compared to untransfected
control cells (Figure 6A). To determine whether the decrease in p-
Smad2/3 protein levels observed after NFI-C overexpression was
NFI-C and TGF-b1 Signaling in Odontoblast
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Figure 3. Degradation of NFI-C by TGF-b1 induction requires Smad3 in MDPC-23 cells. (A) MDPC-23 cells were transfected with empty
vector (pCMV empty vector, control), Smad2, or Smad3 expression vectors in the presence or absence of MG132. NFI-C protein levels were analyzed
by western blot 48 hr post-transfection. GAPDH was used as a loading control. (B) HEK293T cells were co-transfected with HA-tagged NFI-C and
FLAG-tagged Smad3 (F-Smad3) expression vectors for 48 hr and then lysed. The whole cell lysates (WCL) and NFI-C immunoprecipitates were
analyzed by western blot with anti-FLAG antibody. (C) Co-localization of NFI-C (red) and FLAG-Smad3 (green). MDPC-23 cells were co-transfected
with NFI-C and FLAG-tagged Smad3 expression vector for 48 hr. After 48 hr, transfected cells were stimulated with TGF-b1 for 1 hr in the presence of
MG132 (10 mM). Double immunostaining was performed with anti-NFI-C and anti-FLAG antibodies, followed by the secondary antibodies conjugated
to goat anti-rabbit rhodamine (red, NFI-C) and goat anti-mouse FITC (green, FLAG-Smad3), respectively. The merged panel shows co-localization
(yellow) of NFI-C and FLAG-Smad3 in the cytoplasm. DAPI staining was used to detect nuclei. (D) MDPC-23 cells were stimulated with TGF-b1 (10 ng/
ml) in the presence of the proteasome inhibitor, MG132 (10 mM) for 1 hr. Cytoplasmic and nuclear fractions were isolated and NFI-C
immunoprecipitates were analyzed by western blot with the anti-NFI-C or anti-pSmad3 antibody. GAPDH and lamin B served as cell fractionation
controls. (E) MDPC-23 cells were transfected with shRNA Smad3 expression vector or control empty vector. Knockdown of Smad3 was evaluated by
RT-PCR (left panel). Cell lysates were analyzed by western blot with NFI-C antibody, and the results were quantified using ImageJ (right panel;
*P,0.01).
doi:10.1371/journal.pone.0029160.g003
NFI-C and TGF-b1 Signaling in Odontoblast
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e29160
due to the degradation of p-Smad2/3 protein, we measured the
polyubiquitination of p-Smad2/3 after overexpression of NFI-C
in MDPC-23 cells. Polyubiquitination of endogenous p-Smad2/3
was hardly affected by NFI-C overexpression (Figure 6B). Based
on these findings, we suggest that NFI-C overexpression resulted
in a decrease in p-Smad2/3 protein levels, not via the
degradation of p-Smad2/3 but the dephosphorylation of p-
Smad2/3.
Figure 4. Ubiquitination and degradation of NFI-C by TGF-b1 is mediated by the ubiquitin ligase, Smurf1. (A) MDPC-23 cells were co-
transfected with NFI-C, Smurf1, Smurf2, Nedd4, and Praja1 expression vectors for 48 hr. After 48 hr, transfected cells were incubated with or without
TGF-b1 (10 ng/ml) for 1 hr. NFI-C protein levels were analyzed by western blot. GAPDH was used as a loading control. (B) MDPC-23 cells were co-
transfected with NFI-C and Smurf1 expression vector for 48 hr. After 48 hr, transfected cells were incubated with or without TGF-b1 (10 ng/ml) in the
presence or absence of MG132 for 1 hr. NFI-C protein levels were analyzed by western blot. (C) MDPC-23 cells were transfected with shRNA Smurf1
expression vector or control empty vector. Forty-eight hours post-transfection cells were stimulated with TGF-b1 for 1 hr. Cell lysates were analyzed
by western blot with NFI-C antibody (left panel), and the results were quantified using ImageJ. Knockdown of Smurf1 was evaluated by real time PCR
(right panel). (D) HEK293T cells were co-transfected with HA-tagged NFI-C, FLAG-tagged ubiquitin (Ub), and Smurf1, and then treated with MG132
(5 mM) for 48 hr. Forty-eight hours post-transfection, cells were stimulated with TGF-b1 for 1 hr. The NFI-C immunoprecipitates or whole cell lysates
(WCL) were analyzed by western blot with anti-FLAG or anti-HA antibody.
doi:10.1371/journal.pone.0029160.g004
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Discussion
In Nfic-deficient mice, both the expression of TGF-b1 and TGFb-
RI, and the phosphorylation of Smad2/3 increase during odontoblast
differentiation, leading to formation of abnormal dentin similar to
osteodentin [15]. Mice in which NFI-C is disrupted are morpholog-
ically similar in terms of tooth dentin to TGF-b1-overexpressing
transgenic mice [16]. The results of this study imply that a functional
relationship exists between NFI-C and TGF-b1 signaling during
odontoblast differentiation. Here, we investigated the mechanism of
odontoblast differentiation by examining the mutual interaction
between NFI-C and TGF-b1 signaling, and the degradation and
ubiquitination of NFI-C by TGF-b1.
TGF-b1 induces cell growth arrest by activating p21, the cyclin-
dependent kinase inhibitor, through the Smad signaling pathway
[22]. Activation of p21 also induces keratinocyte differentiation
Figure 5. NFI-C interaction with Smurf1 requires activation of the MAPK pathway by TGF-b signaling. (A) MDPC-23 cells were treated
with TGF-b1 (10 ng/ml) for 1 hr and then lysed. The NFI-C immunoprecipitates or whole cell lysates (WCL) were subjected to western blot analysis with
the anti-Smurf1 or anti-NFI-C antibody. GAPDH was used as a loading control. (B) HEK293T cells were co-transfected with HA-tagged NFI-C and FLAG-
tagged Smurf1 expression vectors for 48 hr. WCL and NFI-C immunoprecipitates were analyzed by western blot with anti-FLAG or anti-HA antibody. (C)
MDPC-23 cells were incubated with TGF-b1 (1 hr, 10 ng/ml) in the presence or absence of the MEK inhibitor, U0126 (10 mM), added 1 hr prior to TGF-b1
addition. Cells were lysed, and NFI-C, p-ERK, and GAPDH levels were analyzed by western blot. (D) MDPC-23 cells were stimulated with TGF-b1 (10 ng/
ml) for 1 hr in the presence or absence of the MEK inhibitor, U0126 (10 mM). WCL and NFI-C immunoprecipitates were analyzed by western blot. (E) WCL
and anti-phospho-Ser/Thr-Pro immunoprecipitates were analyzed by western blot with anti-NFI-C antibody. (F) HA-tagged NFI-C protein was
metabolically labeled with [c-32P]-ATP in HEK293T cells. Bound Smurf1 proteins were eluted from the beads and detected by western blot analysis with
the indicated antibody. The incorporation of 32P was detected by autoradiography, and the amount of HA-NFI-C was detected by western blot analysis.
doi:10.1371/journal.pone.0029160.g005
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[23]. Interestingly, NFI is an important factor in the inhibition of
p21 expression in proliferating Hela cells [24]. In the present
study, TGF-b1 induced the degradation of the NFI-C protein in
both the cytoplasm and nucleus through the proteasome pathway,
and NFI-C was degraded by the overexpression of Smad2 and
Smad3. However, when Smad3 was inactivated by knockdown,
TGF-b1 could not affect the degradation of NFI-C. Based on these
findings, we suggest that TGF-b1 induces odontoblast differenti-
ation through the Smad signaling pathway by increasing p21 and
TGF-b-responsive gene expression levels via the degradation of
NFI-C, which suppresses p21 expression.
In the present study, we showed that NFI-C interacts with
Smad3 and is degraded in the cytoplasm and nucleus, which
increases in response to stimulation with TGF-b1. Interestingly,
the amount of Smad3 binding to NFI-C after TGF-b1 stimulation
is increased in cytoplasm but decreased in the nucleus. Therefore,
we suggest that in the cytoplasm, phosphorylated Smad3 induced
by TGF-b1 stimulation increases binding to NFI-C, and results in
the degradation of NFI-C.
NFI-C does not contain a polyproline-tyrosine motif, whereas a
database search identified many SP sites and Ser/Thr protein
kinase phosphorylation sites (SSXS), in the C-terminal region of
NFI-C [13]. Recently, Smurf1 binding was shown to require the
phosphorylation of SP sites located upstream of the PPAY motif in
Smad1. MAPK-induced phosphorylation of the Smad1 linker
region through bone morphogenetic protein signaling is recog-
nized by Smurf1 and leads to the ubiquitination and degradation
of Smad1 [25]. TGF-b1 also enhances the phosphorylation of the
Smad2/3 linker regions by MAPK, which is involved with E3 Ub
ligases, such as Nedd4L [26]. In the present study, we show that
the interaction between NFI-C and Smurf1/Smurf2 were also
required for the activation of MAPK-ERK by TGF-b1 signaling.
Interestingly, TGF-b1-induced NFI-C binding to Smurf1 and
Smurf2 was inhibited not by a combination of a p38 inhibitor but
by a JNK inhibitor (data not shown). It suggests that JNK pathway
is also involved in the interaction between NFI-C and Smurf1/
Smurf2 induced by TGF-b1. Therefore, JNK pathway needs
further investigation. Possible interaction motifs regulating the
binding of NFI-C and either Smurf1 or Smurf2 are also currently
under investigation.
When Smad signaling is continuously inhibited by the
absence of TGF-b signaling, endogenous levels of Smad2 and
Smad3 are negatively regulated by a number of proteins,
including Smurfs. Smad2 and Smad3 show enhanced ubiqui-
tination and degradation by Smurf2 and WW domain-
containing protein 2 [27,28]. In addition, the Axin and Ub
ligase complex ROCK1 induces the degradation and ubiquiti-
nation of Smad3 [29,30]. Therefore, we investigated whether
the expression of Smad2/3 and/or Smad3 protein was affected
by NFI-C in odontoblasts. NFI-C overexpression remarkably
decreased the level of p-Smad2/3 and p-Smad3 protein via the
dephosphorylation of p-Smad2/3 and p-Smad3 in MDPC-23
cells. These results suggest that NFI-C is a novel negative
regulator of TGF-b1 signaling during odontoblast differentia-
tion in tooth development. Recently, it was reported that NFI-C
acts primarily to repress gene expression in response to TGF-b1
during wound healing [31]. This report has also provided
evidence in support of our data.
To investigate whether the NFI-C interaction with TGF-b1
occurs in cell types other than odontoblasts, we measured the
effects of TGF-b1 treatment on endogenous NFI-C protein levels
in the human breast epithelial cell line, MCF10A. Expression of
NFI-C was clearly observed in MCF10A cells. The level of NFI-C
protein decreased in response to TGF-b1 treatment (Figure S7).
These results demonstrate that degradation of NFI-C induced by
TGF-b1 occurs generally in cell types other than odontoblasts in
normal human breast epithelial cells.
In conclusion, as shown in Figure 7, these results demonstrate
that interactions between NFI-C and TGF-b1 signaling play key




Antisera against NFI-C and DSP were produced as described
previously [15]. Mouse monoclonal anti-hemagglutinin (HA;
MMS-101P) and anti-FLAG (M2 and F3165) antibodies were
purchased from COVANCE (Emeryville, CA) and Sigma-Aldrich
(St Louis, MO), respectively. Rabbit anti-p-Smad3 and total
Smad2/3 antibodies were purchased from Cell Signaling Tech-
nology (Danvers, MA). Mouse monoclonal anti-Runx-2 antibody
was a gift from Dr. H-M Ryoo (Department of Cell and
Developmental Biology, School of Dentistry, Seoul National
University, Seoul, Korea). All other antibodies against TGFb-RI
(sc-398), TGFb-RII (sc-400), p-Smad2/3 (sc-11769), p21 (sc-6246),
and Osterix (sc-22538) were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA).
Figure 6. Dephosphorylation of p-Smad2/3 by NFI-C in MDPC-23 cells. (A) MDPC-23 cells were transfected with NFI-C expression vector for
48 hr. The level of NFI-C, p-Smad2/3, p-Smad3, and total Smad2/3 (T-Smad2/3) protein were analyzed by western blot. GAPDH was used as a loading
control. (B) MDPC-23 cells were transfected with HA-tagged NFI-C and FLAG-tagged ubiquitin (Ub) expression vector for 48 hr. The FLAG
immunoprecipitates or whole cell lysates (WCL) were analyzed by western blot.
doi:10.1371/journal.pone.0029160.g006
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Plasmid construction
pCH-NFIC, Samd2, and Smad3 expression plasmids were
constructed, as described previously [15]. Smurf1, Smurf2, Nedd4,
Praja1, TGFb-RI (TD), MEK-CA, and FLAG-Ub plasmids were
kind gifts from Dr. H-M Ryoo.
siRNAs were synthesized (Integrated DNA Technologies, San
Diego, CA) based on the chosen 19 nucleotides of NFI-C (59-CCG
GTG AAG AAG ACA GAG A-39), Smad3 (59-ATC CGT ATG
AGC TTC GTC A-39), and Smurf1 (59-GAA CCT TGC AAA
GAA AGA C-39), and these siRNA-expression plasmids were
prepared using the pSUPER-retro-neo-GFP retro virus siRNA
expression vector (OligoEngine, Seattle, WA), according to the
manufacturer’s instructions.
Cell culture, transfection, and TGF-b1 stimulation
MDPC-23 (a generous gift from Dr. J. E. Nör, School of Dental
Medicine, University of Michigan, MI), and HEK293T cells
(ATCC, Rockville, MD) were grown and maintained in
Dulbecco’s modified Eagle’s medium (DMEM, Gibco BRL,
Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS,
Gibco BRL) and antibiotics (Penicillin-G 100 U/ml, streptomycin
100 mg/ml, fungizone 2.5 mg/ml, Gibco BRL) in 5% CO2 in a
37uC incubator. To induce MDPC-23 cell differentiation, 80–90%
confluent cells were cultured in DMEM supplemented with 5%
FBS, ascorbic acid (50 mg/ml), and b-glycerophosphate (10 mM)
for up to 3 weeks.
The indicated expression plasmid (2 mg) was transiently
transfected into MDPC-23 cells using Lipofectamine PlusTM
reagent (Invitrogen) according to the manufacturer’s instructions.
MDPC-23 cells were stimulated with TGF-b1 (10 ng/ml,
Invitrogen), TGF-b2 (10 ng/ml, PeproTech, Rocky Hill, NJ), or
TGF-b3 (10 ng/ml, PeproTech) at 37uC for 1 hr. The chemical
inhibitors, U0126 (ERK inhibitor, 10 mM, Calbiochem, La Jolla,
CA), SB203580 (p38 inhibitor, 10 mM, Sigma-Aldrich), SP600125
(JNK inhibitor, 10 mM, Sigma-Aldrich), and MG132 (10 mM,
Sigma-Aldrich) were added to MDPC-23 cells 1 hr prior to
treatment with TGF-b1.
Retroviral production and virus infection
Platinum-E cells were transfected with a pSUPER-retro-neo-
GFP retrovirus vector that encodes NFI-C, Smad3, or Smurf1
siRNA, or empty vector using Lipofectamine PlusTM reagent
(Invitrogen). After 48 hr, viral supernatants were harvested and
filtered using a 0.45-mm syringe filter. MDPC-23 or MCF10A cells
(ATCC) were infected with virus supernatant in the presence of
Polybrene (6 mg/ml).
Figure 7. A proposed model of the function of NFI-C and TGF-b1 during odontoblast differentiation and homeostasis. During early
odontoblast differentiation, p-Smad2/3 induced by TGF-b1 signaling increased binding to NFI-C in the cytoplasm. On the other hand, MAPK
activation by TGF-b1 signaling increased the interaction of phosphorylated NFI-C and Smurf1/2. Collectively, TGF-b1 and MAPK activation enhanced
the interaction and formation of Smad2/3-NFI-C-Smurf1/2 complex and resulted in the degradation of NFI-C. In contrast, during late odontoblast
differentiation and mineralization, NFI-C signaling resulted in the dephosphorylation of p-Smad2/3. Consequently, TGF-b1 induces odontoblast
differentiation through the Smad signaling pathway in early odontoblast differentiation, while NFI-C signaling modulates late odontoblast
differentiation and mineralization.
doi:10.1371/journal.pone.0029160.g007
NFI-C and TGF-b1 Signaling in Odontoblast
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29160
Reverse transcription (RT)-PCR and real-time PCR analysis
Total RNA was extracted from the MDPC-23 cells with
TRIzolH reagent according to the manufacturer’s instructions
(Invitrogen). Total RNA (2 mg) was subjected to reverse transcrip-
tion with 0.5 mg Oligo dT and 1 ml (50 IU) Superscript III enzyme
(Invitrogen) in a 20-ml reaction mixture at 50uC for 1 hr. The
resulting mixture was amplified by PCR. One microliter of the
reverse transcription product was subjected to PCR: 32 cycles of
94uC for 0.5 min, 55uC for 0.5 min, 72uC for 0.5 min. For RT-
PCR, specific primers for DMP-1, ColIa1, Smad3, and GAPDH
were synthesized as listed in Table S1. The PCR products were
electrophoresed on a 1.2% agarose gel, stained with ethidium
bromide, and visualized under ultraviolet light.
For real-time PCR, specific primers for NFI-C, DSPP, osteocalcin,
Smad3, Smurf1, and HPRT were synthesized as listed in Table S2.
Real-time PCR was performed on an ABI PRISM 7500 sequence
detection system with SYBR GREEN PCR Master Mix (Applied
Biosystems, Foster City, CA) according to the manufacturer’s
instructions. The PCR conditions were 94uC for 1 min followed
by 95uC for 15 s and 60uC for 34 s for 40 cycles. All reactions
were run in triplicate and were normalized to the housekeeping
gene, HPRT. The relative differences in PCR results were
calculated using the comparative cycle threshold (CT) method.
Western blot analysis and immunoprecipitation
Western blot analysis was performed as previously described
[15]. Briefly, the proteins (30 mg) were separated by 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
transferred onto a nitrocellulose membrane (Schleicher & Schuell
BioScience, Dassel, Germany), and labeled with specific antibod-
ies. Labeled protein bands were detected using an enhanced
chemiluminescence system (GE Healthcare, Buckinghamshire,
UK), and bands were measured by densitometric analysis.
To prepare nuclear extracts, cells were resuspended in a
hypotonic solution (10 mM HEPES, 10 mM KCl, and protease
inhibitors) and incubated for 10 min on ice. Nonyl phenoxypo-
lyethoxylethanol (NP-40) was added to a final concentration of
0.1%, and the nuclei were isolated by centrifugation at 1,0006 g
for 10 min at 4uC. Nuclei were washed three times with the same
hypertonic solution. After removal of the supernatant, nuclei were
resuspended in a nuclear lysis solution (10 mM HEPES, pH 7.5,
150 mM NaCl, 1% NP-40, 0.25% Na-deoxycholate, 10%
glycerol, and protease inhibitors) and centrifuged at 16,0006 g
for 45 min at 4uC. For immunoprecipitation analysis, 500 mg
precleared cell extracts were incubated with anti-HA antibody at
4uC overnight with constant rotation and then incubated at 4uC
for 3 hr with 20 ml Protein A/G beads (Santa Cruz Biotechnol-
ogy). The beads were washed extensively five times, resuspended
in 26 Laemmli sample buffer, and boiled at 100uC for 5 min.
Samples were resolved by 10% SDS-PAGE and analyzed by
western blot using anti-FLAG and anti-HA antibodies. Densitom-
etry was performed using ImageJ software (http://rsb.info.nih.
gov/ij).
Ubiquitination assay
Transfected HEK293T cells were incubated with 10 mM
MG132 (Sigma-Aldrich). For the detection of recombinant Ub,
cells were co-transfected with pFLAG-Ub and an expression
vector pCH-NFI-C (tagged-HA). For immunoprecipitation anal-
ysis, cells were lysed in 100 ml TBS buffer (20 mM Tris, pH 7.5,
150 mM NaCl, and 2% SDS), boiled for 15 min, and briefly
sonicated. The lysates were diluted with 900 ml TNX dilution
buffer (20 mM Tris, pH 7.5, 150 mM NaCl, and 1% TritonX-
100) and centrifuged at 16,0006 g at 4uC for 45 min. Cleared
lysate (1 mg) was subjected to immunoprecipitation with the anti-
HA antibody. Enriched Ub-conjugated proteins were resolved by
8% SDS-PAGE and analyzed by western blot using anti-HA or
anti-FLAG antibodies.
Kinase assay and in vitro binding assay
HEK293T cells were co-transfected with NFI-C and MEK-CA
expression plasmids, and cultured for 24 hr. Labeling was
conducted for 2 hr in DMEM-0.1% FBS medium containing
100 mCi [c-32P]-adenosine triphosphate (ATP; PerkinElmer Life
Sciences, Inc. Waltham, MA). Whole cell lysates were prepared as
previously described [15]. Pre-cleared cell extracts were incubated
with anti-HA antibody at 4uC overnight with constant rotation,
and then incubated at 4uC for 3 hr with 20 ml Protein A/G beads
(Santa Cruz Biotechnology). The beads were washed five times.
Purified HA-NFI-C protein A/G beads were incubated with or
without lambda protein phosphatase (New England Biolabs,
Ipswich, MA) at 30uC for 1 hr. For interaction assay, beads were
incubated with HEK293T lysates expressing FLAG-tagged
Smurf1 and Smurf2 proteins at 4uC for 2 hr. The beads were
washed twice and boiled in Laemmli sample buffer for western
blot analysis. The incorporation of 32P into ERK-phosphorylated
HA-NFI-C was detected by autoradiography.
Immunofluorescence microscopy
MDPC-23 cells were cultured on Laboratory-Tek chambered
coverglasses (Nunc, Rochester, NY) and stimulated with TGF-b1
(10 ng/ml, Invitrogen) at 37uC for 1 hr. The chemical inhibitor
MG132 (10 mM, Sigma-Aldrich) was added to MDPC-23 cells
1 hr prior to treatment with TGF-b1. For fluorescence microsco-
py, the cells were fixed with 4% paraformaldehyde in PBS at 4uC
for 20 min, permeabilized with 0.15% Triton X-100 in PBS for
10 min, and then pre-incubated with 1% bovine serum albumin in
PBS for 30 min. Cells were incubated for 2 hr with rabbit-anti-
NFI-C antibody (1:100), washed three times with PBS, and then
incubated for 45 min with a fluorescent secondary antibody
(rabbit-anti-IgG-FITC, 1:500, Invitrogen) and counterstained with
49-6-diamidino-2-phenylindole (DAPI). Cells were examined by
confocal laser scanning microscopy (Olympus, Tokyo, Japan).
Statistical analysis
Data were analyzed for statistical significance using a non-
parametric Mann-Whitney test.
Supporting Information
Figure S1 The mRNA expression levels of osteocalcin,
DSPP, ColIa1, and DMP-1 during odontoblast differen-
tiation. Expression of OC (A) and DSPP (B) mRNA analyzed by
real-time PCR. Expression of ColIa1 (C) and DMP-1 (D) mRNA
analyzed by RT-PCR. The results were quantified using ImageJ.
Data are presented as the mean 6 standard deviation (SD) for
three separate experiments. An asterisk denotes values significantly
different from the control (0 day) using a nonparametric Mann-
Whitney test (* P,0.01).
(TIF)
Figure S2 NFI-C is degraded by TGF-b1 in MDPC-23
cells. (A) MDPC-23 cells were incubated with TGF-b1 (10 ng/
ml), TGF-b2 (10 ng/ml), and TGF-b3 (10 ng/ml) for 1 hr. NFI-C
protein levels were analyzed by western blot. GAPDH was used as
a loading control. (B) MDPC-23 cells were transfected with empty
vector (pCMV empty vector, control) or TGFb-RI. TGFb-RI and
NFI-C protein levels were analyzed by western blot 48 hr post-
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transfection. GAPDH was used as a loading control. (C) MDPC-
23 cells were treated with 0.1, 1, 5, 10, or 100 ng/ml TGF-b1 for
1 hr. NFI-C protein levels were analyzed by western blot.
(TIF)
Figure S3 Effects of NFI-C, Smad3, and TGF-b1 on
mRNA expression levels of NFI-C and Smad3 in MDPC-
23 cells. MDPC-23 cells were transfected with NFI-C, Smad3,
siRNA NFI-C, and siRNA Smad3 expression vector or control
empty vector for 48 hr, and treated with TGF-b1 (10 ng/ml).
Expression of (A) NFI-C and (B) Smad3 mRNA were analyzed by
real-time PCR.
(TIF)
Figure S4 Ubiquitination and degradation of NFI-C by
TGF-b1 is mediated by the ubiquitin ligase, Smurf2. (A)
MDPC-23 cells were co-transfected with NFI-C and Smurf2
expression vector for 48 hr. Forty-eight hours post-transfection,
cells were incubated with or without TGF-b1 (10 ng/ml) in the
presence or absence of MG132 for 1 hr. NFI-C protein levels were
analyzed by western blot. GAPDH was used as a loading control.
(B) HEK293T cells were co-transfected with HA-tagged NFI-C,
FLAG-tagged ubiquitin (Ub), and Smurf2 and treated MG132
(5 mM) for 48 hr. After 48 hr, transfected cells were stimulated
with TGF-b1 for 1 hr. The NFI-C immunoprecipitates (left panel)
or whole cell lysates (right panel) were analyzed by western blot
with anti-FLAG or anti-HA antibody.
(TIF)
Figure S5 NFI-C interaction with Smurf2 requires the
activation of the MAPK pathway by TGF-b signaling. (A)
MDPC-23 cells were treated with TGF-b1 (10 ng/ml) for 1 hr
and then lysed. The NFI-C immunoprecipitates or whole cell
lysates (WCL) were subjected to western blot analysis with the
anti-Smurf2 or anti-NFI-C antibody. GAPDH was used as a
loading control. (B) HEK293T cells were co-transfected with
HA-tagged NFI-C and FLAG-tagged Smurf2 expression vectors
for 48 hr. Cells were incubated with TGF-b1 (10 ng/ml) for
1 hr. WCL and NFI-C immunoprecipitates were analyzed by
western blot with anti-FLAG or anti-HA antibody. (C) MDPC-
23 cells were stimulated with TGF-b1 (10 ng/ml) for 1 hr in the
presence or absence of the MEK inhibitor, U0126 (10 mM).
WCL and NFI-C immunoprecipitates were analyzed by western
blot. (D) HA-tagged NFI-C protein was metabolically labeled
with [c-32P]-ATP in HEK293T cells. Phosphorylated HA-NFI-
C was incubated with or without l phosphatase at 30uC for 1 hr.
Phosphorylated and dephosphorylated HA-NFI-C was incubated
with HEK293T lysates expressing the FLAG-tagged Smurf2 for
2 hr at 4uC. Bound Smurf2 proteins were eluted from the beads
and detected by western blot analysis with the indicated
antibody. The incorporation of 32P was detected by autoradi-
ography, and the amount of HA-NFI-C was detected by western
blot analysis.
(TIF)
Figure S6 Phosphorylation of NFI-C is increased by the
activation of MAPK. HEK293T cells were co-transfected
with HA-tagged NFI-C and MEK-CA expression vectors for
48 hr. Whole cell lysates and anti-phospho-Ser/Thr-Pro
immunoprecipitates were analyzed by western blot with anti-
HA antibody.
(TIF)
Figure S7 NFI-C is degraded by TGF-b1 in normal
human breast epithelial cells. Normal human breast
epithelial cells (MCF-10A cells) were cultured in DMEM/F12
supplemented with 5% horse serum, insulin (0.01 mg/ml), EGF
(20 ng/ml), cholera toxin (100 ng/ml), hydrocortisone (500 ng/
ml), 2 mM L-glutamine, and antibiotics. Cells were infected with
retroviral supernatant containing NFI-C siRNA and/or NFI-C for
overexpression or empty vector, and treated with TGF-b1 (10 ng/
ml) for 1 hr. NFI-C protein levels were measured by western blot
analysis (left panel), and the results were quantified using ImageJ
(right panel). GAPDH was used as a loading control.
(TIF)
Table S1 Nucleotide sequences of RT- PCR primer
pairs.
(DOC)
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